Allergan Files Lawsuit Against ValeantBy
Allergan, Inc. reported on August 1 that it had filed a lawsuit in the
“After careful consideration,
Specifically, as the complaint alleges, Allergan said that between
In response, J. Michael Pearson, chairman and chief executive officer of Valeant, said “We are disappointed that
Pershing Square is targeting the middle of August for delivering shareholder requests to call a special meeting. :The independent proxy advisory firms are expected to issue their recommendations on this matter in the near future, and this lawsuit also seeks to distract from those forthcoming recommendations,” said Valeant in a statement.
Source: Allergan and Valeant Pharmaceuticals